Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer

Annals of Surgical Oncology

Volumn 5, Issue 8, 1998, Pages 681-688

  Bouvet, Michael ^a   Bold, Richard J ^a   Lee, Julia ^c   Evans, Douglas B ^a   Abbruzzese, James L ^a   Chiao, Paul J ^a   McConkey, David J ^a   Chandra, Joya ^a   Chada, Sunil ^c   Fang, Bingliang ^b   Roth, Jack A ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Introgen Therapeutics Inc   (United States)

Author keywords

Apoptosis; Gene therapy; p53 Pancreatic cancer

Indexed keywords

PROTEIN P53;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; GENE CONSTRUCT; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS CANCER; REPORTER GENE; TUMOR SUPPRESSOR GENE;

EID: 0031648811     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303477     Document Type: Article

References (30)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1998;48:6-29.
2. Evans DB, Abbruzzese JL, Rich TA. Cancer of the pancreas. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997:1054-81.
3. Vogelstein B. Cancer: a deadly inheritance. Nature 1990;348: 681-2.
4. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1989;253:49-53.
5. Mukhopadhyay T, Maxwell SA, Roth JA. p53 suppressor gene. Austin, TX: RG Landes, 1995.
6. Redston MS, Caldas C, Seymour AB, et al. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 1994; 54:3025-33.
7. Ruggeri B, Zhang SY, Caamano J, Dirado M, Flynn SD, Klein-Szanto AJ. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-l tumor suppressor genes. Oncogene 1992;7:1503-11.
8. Casey G, Yamanaka Y, Friess H, et al. p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett 1993;69:151-60.
9. Barton CM, Staddon SL, Hughes CM, et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 1991;64:1076-82.
10. Pellegata NS, Sessa F, Renault B, et al. K-ras and p53 mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994;54:1556-60.
11. Nakamori S, Yashima K, Murakami Y, et al. Association of p53 gene mutations with short survival in pancreatic adenocarcinoma. Jpn J Cancer Res 1995;86:174-81.
12. Zhang WW, Fang X, Mazur W, French BA, Georges RN, Roth JA. High-efficiency gene transfer and high-level expression of wildtype p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1994;1:5-13.
13. Liu TJ, El-Naggar AK, McDonnell TJ, et al. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res 1995;55:3117-22.
14. Spitz FR, Nguyen D, Skibber JM, Cusack J, Roth JA, Cristiano RJ. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. Anticancer Res 1996;16:3415-22.
15. Zhang WW, Alemany R, Wang J, Koch PE, Ordonez NG, Roth JA. Safety evaluation of Ad5CMV-p53 in vitro and in vivo. Hum Gene Ther 1995;6:155-64.
16. Berrozpe G, Schaeffer J, Peinado MA, Real FX, Perucho M. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer 1994;58:185-91.
17. Graham FL. Prevec L. Manipulation of adenovirus vectors. In: Murray E, cd. Methods in Molecular Biology: Gene Transfer and Expression Protocols. Vol. 7. Clifton, NJ: The Human Press, 1991: 205-25.
18. Boviatsis EJ, Chase M, Wei MX, et al. Gene transfer into experimental brain turnors mediated by adenovirus, Herpes simplex virus, and retrovirus. Hum Gene Ther 1994;5:183-91.
19. Nicoletti I. Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-9.
20. McConkey DJ, Hartzell P, Jondal M. Orrenius S. Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J Biol Chem 1989;264: 13399-402.
21. Gavrieli Y, Sherman Y. Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
22. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447-58.
23. Staley CA, Lee JE, Cleary KA, Abbruzzese JL, Rich TA, Evans DB. Preoperative chemoradiation, pancreatoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head: patient survival and patterns of treatment failure. Am J Surg 1996;171:118-25.
24. Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancrealicoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997;15:928-37.
25. Kaiser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-903.
26. Howe JR. Conlon KC. The molecular genetics of pancreatic cancer. Surg Oncol 1997;6:1-18.
27. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, OwenSchaub LB, Roth JA. Induction of chemosensitivity in human lung cancer cells in vivo by adenoviral-mediated transfer of the wild-type p53 gene. Cancer Res 1994;54:2287-91.
28. Spitz FR, Nguyen D, Skibber JM, Meyn RE, Cristiano RJ, Roth JA. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin Cancer Res 1996; 2:1665-71.
29. Horowitz JA, Mancval DC, Rybak ME. Intra-arterial p53 gene therapy of liver malignancies: preclinical studies and initial clinical observations. Cancer Gene Ther 1997;4:S12.
30. Yang L, Hwang R, Pandit L, Gordon EM, Anderson WF, Parekh D. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir. Ann Surg 1996;224:405-17.